Stem cells and the immune system: can they really strengthen immunity?

One of the most frequently cited MSC properties is immunomodulation — the ability to interact with various immune cells, such as T cells and macrophages, to help keep inflammation at an appropriate balance, neither excessive nor insufficient. This property is the basis for studying MSCs in chronic inflammatory conditions and autoimmune disease.

In medical terms, 'immunity' splits into innate immunity — the first line of defence that reacts immediately to foreign material — and adaptive immunity, which develops a pathogen-specific response, as vaccination does. Claims that stem cells 'strengthen immunity' should be understood as helping rebalance overall immune system function, not as generating pathogen-specific protection the way a vaccine does.

Cheongdam Cell Clinic explains its 淸(Rejuvenation)CELL rationale as stem cells supporting immune-system regeneration and vascular renewal, tied to the anti-ageing process. It also cites application in chronic inflammatory and autoimmune conditions such as atopic dermatitis, psoriasis and rheumatoid arthritis — a group of conditions that international MSC research has likewise focused on.

That said, patients should be clear that 'supporting immune function' differs from 'curing' or '100% preventing' disease. Most academic MSC research in autoimmune and chronic inflammatory conditions remains at various stages of clinical study, with results varying by disease type, cell dose and delivery method — there is no unanimous conclusion across every indication.

The mechanisms believed to be involved include secreting anti-inflammatory cytokines, stimulating regulatory T cells that keep the immune system from attacking the body's own tissue, and dampening overactive pro-inflammatory immune cells. These are cellular and molecular-level effects that require laboratory testing to confirm — they cannot be observed by eye immediately after treatment.

Patients who already have an autoimmune or chronic inflammatory condition and are considering stem cell treatment should consult their primary treating physician as well, and should not stop existing medication without medical advice, since stem cell treatment today is generally viewed as adjunctive rather than a replacement for well-evidenced standard care.

Overall, the concept of stem cells interacting with the immune system has an interesting scientific basis and is part of the rationale Cheongdam Cell Clinic presents for its 淸(Rejuvenation)CELL programme. Patients should, however, interpret 'immune support' carefully, distinguishing between studied biological mechanisms and a guaranteed clinical outcome, which is not yet settled for every case.